CVS Health reported a strong third quarter, highlighted by its ability to administer COVID-19 vaccinations and a stark increase in sales for its front-of-store retail business.
The two could be related, as vaccines helped drive foot traffic, according to Placer.ai and its report of activity at CVS and Walgreens, recording a rise in foot traffic north of 40% for the chains in August, and a rise of 22% and 26% in September for CVS and Walgreens, respectively.
For the quarter, CVS reported its front-of-store sales increased 22% for the retail/long-term care segment for the quarter vs. the same period a year ago. Overall, the Woonsocket, R.I.-based chain saw Q3 revenues up 10% year over year, totaling $73.8 billion. Total revenues year to date increased to $215.5 billion, an increase of 8.2% compared with the prior-year period. GAAP diluted earnings per share were $4.98 and adjusted earnings per share were $6.43.
“We outperformed expectations once again and continue to lead the way in changing how, when and where care is delivered for millions of Americans,” said CVS Health president and CEO Karen Lynch. “Our services are responsive to evolving consumer needs, from administering millions of COVID-19 tests and vaccines to offering primary care accessible from virtually anywhere, and our touchpoints allow for unmatched impact."